# Larimar Therapeutics Inc. (LRMR) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $3.83, market value $398 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Larimar Therapeutics Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 3.1×**. The shares trade at 3.1× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -28.5%** (5-yr avg -24.0%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -212.2%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -321.6%**. Return on all capital, debt included, is -321.6%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -15.9%**. Each dollar of assets produces -15.9% of profit.

## Financial health
- **Debt to equity: 0.19**. Debt is 0.19 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 3.1×**. It would take 3.1 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Interest coverage: -13.1×**. Operating profit covers interest only -13.1×: fragile.
- **Current ratio: 2.19** (quick 2.19). Current assets cover the next year's liabilities 2.19 times.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Larimar Therapeutics Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -1.0%** (YTD 0.5%, 3-mo 20.8%). The shares are down 1.0% over twelve months including dividends.
- **From 52-week high: -40.3%** (41.1% above the low). Trading 40% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 43**. An RSI of 43 is neutral.
- **Beta (1 yr): 1.82** (volatility 109%). Beta of 1.82 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=LRMR · Page: https://foliofundamentals.com/stocks/lrmr

Not investment advice.